Axsome Therapeutics, Inc.

GLENMEDE TRUST CO NA AXSM

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

6,924

Value ($000)

1,265

Weight

0.0%

2019 Q4 - 2025 Q4 (21 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	1,265	0.0%	6,924	12/31/2025
2025 Q1	5/15/2025	887	0.0%	7,607	3/31/2025
2024 Q4	2/14/2025	462	0.0%	5,466	12/31/2024
2024 Q3	11/13/2024	672	0.0%	7,473	9/30/2024
2024 Q2	8/14/2024	596	0.0%	7,403	6/30/2024
2024 Q1	5/15/2024	583	0.0%	7,302	3/31/2024
2023 Q4	2/13/2024	586	0.0%	7,365	12/31/2023
2023 Q3	11/14/2023	573	0.0%	8,203	9/30/2023
2023 Q2	8/14/2023	257	0.0%	4,172	6/30/2023
2023 Q1	5/15/2023	257	0.0%	4,172	3/31/2023
2022 Q4	2/14/2023	506	0.0%	6,562	12/31/2022
2022 Q3	11/16/2022	694	0.0%	15,561	9/30/2022
2022 Q2	8/15/2022	217	0.0%	5,685	6/30/2022
2021 Q4	2/15/2022	209	0.0%	5,535	12/31/2021
2021 Q2	8/16/2021	371	0.0%	5,500	6/30/2021
2021 Q1	5/18/2021	324	0.0%	5,735	3/31/2021
2020 Q4	2/16/2021	462	0.0%	5,675	12/31/2020
2020 Q3	11/16/2020	364	0.0%	5,113	9/30/2020
2020 Q2	8/14/2020	216	0.0%	2,633	6/30/2020
2020 Q1	5/20/2020	527	0.0%	5,106	3/31/2020
2019 Q4	2/12/2020	527	0.0%	5,106	12/31/2019